Antidiabetic AD4743 enhances adipocyte differentiation of 3T3 T mesenchymal stem cells

Publisher Website
Google Scholar
Abstract
AD4743 is an antidiabetic agent that, when added to fetal bovine serum (FBS), has been shown to have adipogenic activity for some proadipocyte cell lines once they reach confluence. In the current study, the effects of AD4743 on the growth and adipocytic differentiation of 3T3 T multipotential mesenchymal stem cells have been tested. 3T3 T cells, unlike other cells capable of undergoing adipocyte differentiation, are routinely induced to differentiate at low cell density. This is done using platelet‐poor human plasma (HP), a potent inducer of growth arrest and differentiation. AD4743 (0–200 μg/ml) was tested in varied concentrations of HP or FBS, at varied cell densities, and at various times during growth and differentiation. AD4743 slowed the growth rate of 3T3 T cells and it induced their differentiation in a dose‐dependent manner in medium containing 10% FBS once they reached confluence. Tiie data suggest that the ability of AD4743 to inhibit growth may also becoupled with its ability to enhance differentiation. In addition, AD4743 (1–10 μg/ml) in the presence of 25% HP markedly increased the kinetics of adipocyte differentiation, at low (< 5,000 cells/cm2) or high cell density. Greater than 50% cell differentiation could be achieved in 2 days in low density cultures; 80–95% differentiation could be achieved in just 4 days, compared to 8–12 days in a typical culture. The maximum amount of differentiation in HP was potentiated by AD4743 to agreater degree in poor lots of HP; however, the kinetics were increased in all lots. Adipocytic differentiation was measured both morphologically and by Northern blot analyses of differentiation‐specific genes. AD4743 at 1–10 μg/ml appeared to be most effective, depending on the cell density and other conditions. The mechanism of action of AD4743 remains to be elucidated, but the enhancement of adipocyte differentiation does not appear to occur via an insulin‐dependent pathway.

This publication has 37 references indexed in Scilit: